137 related articles for article (PubMed ID: 37939428)
41. The role of tumor-associated macrophages in hepatocellular carcinoma progression: A narrative review.
Zhang X; Yu C; Zhao S; Wang M; Shang L; Zhou J; Ma Y
Cancer Med; 2023 Dec; 12(24):22109-22129. PubMed ID: 38098217
[TBL] [Abstract][Full Text] [Related]
42. Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
Sun P; Li Y; Chang L; Tian X
Medicine (Baltimore); 2019 May; 98(19):e15603. PubMed ID: 31083251
[TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
[TBL] [Abstract][Full Text] [Related]
44. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
Zhu XD; Zhang JB; Zhuang PY; Zhu HG; Zhang W; Xiong YQ; Wu WZ; Wang L; Tang ZY; Sun HC
J Clin Oncol; 2008 Jun; 26(16):2707-16. PubMed ID: 18509183
[TBL] [Abstract][Full Text] [Related]
45. Survival impact of immune cells infiltrating peritumoral area of hepatocellular carcinoma.
Yusa T; Yamashita YI; Okabe H; Nakao Y; Itoyama R; Kitano Y; Kaida T; Miyata T; Mima K; Imai K; Hayashi H; Baba H
Cancer Sci; 2022 Dec; 113(12):4048-4058. PubMed ID: 35611468
[TBL] [Abstract][Full Text] [Related]
46. Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis.
Wu SQ; Xu R; Li XF; Zhao XK; Qian BZ
Oncotarget; 2018 May; 9(38):25294-25303. PubMed ID: 29861872
[TBL] [Abstract][Full Text] [Related]
47. The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis.
Yang Z; Zhang M; Peng R; Liu J; Wang F; Li Y; Zhao Q; Liu J
Int J Colorectal Dis; 2020 Sep; 35(9):1651-1661. PubMed ID: 32666290
[TBL] [Abstract][Full Text] [Related]
48. Clinical significance of tumor-associated macrophage infiltration in supraglottic laryngeal carcinoma.
Lin JY; Li XY; Tadashi N; Dong P
Chin J Cancer; 2011 Apr; 30(4):280-6. PubMed ID: 21439250
[TBL] [Abstract][Full Text] [Related]
49. CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.
Li L; Yan J; Xu J; Liu CQ; Zhen ZJ; Chen HW; Ji Y; Wu ZP; Hu JY; Zheng L; Lau WY
PLoS One; 2014; 9(10):e110064. PubMed ID: 25303284
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis.
Sun L; Xu G; Liao W; Yang H; Xu H; Du S; Zhao H; Lu X; Sang X; Mao Y
Oncotarget; 2017 Jun; 8(24):39658-39672. PubMed ID: 28487498
[TBL] [Abstract][Full Text] [Related]
51. The Prognostic and Clinical Value of Tumor-Associated Macrophages in Patients With Breast Cancer: A Systematic Review and Meta-Analysis.
Wang C; Lin Y; Zhu H; Zhou Y; Mao F; Huang X; Sun Q; Li C
Front Oncol; 2022; 12():905846. PubMed ID: 35847911
[TBL] [Abstract][Full Text] [Related]
52. Interleukin-6 induced by YAP in hepatocellular carcinoma cells recruits tumor-associated macrophages.
Zhou TY; Zhou YL; Qian MJ; Fang YZ; Ye S; Xin WX; Yang XC; Wu HH
J Pharmacol Sci; 2018 Oct; 138(2):89-95. PubMed ID: 30340922
[TBL] [Abstract][Full Text] [Related]
53. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
54. Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection.
Zhang H; Wang X; Shen Z; Xu J; Qin J; Sun Y
Gastric Cancer; 2015 Oct; 18(4):740-50. PubMed ID: 25231913
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
[TBL] [Abstract][Full Text] [Related]
56. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
Front Immunol; 2018; 9():2077. PubMed ID: 30254644
[No Abstract] [Full Text] [Related]
57. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis.
Allison E; Edirimanne S; Matthews J; Fuller SJ
Oncol Ther; 2023 Mar; 11(1):27-48. PubMed ID: 36484945
[TBL] [Abstract][Full Text] [Related]
58. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.
Ding T; Xu J; Wang F; Shi M; Zhang Y; Li SP; Zheng L
Hum Pathol; 2009 Mar; 40(3):381-9. PubMed ID: 18992916
[TBL] [Abstract][Full Text] [Related]
59. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
60. Prognostic Value of Tumor-Associated Macrophages in Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Shen H; Liu J; Chen S; Ma X; Ying Y; Li J; Wang W; Wang X; Xie L
Front Oncol; 2021; 11():657318. PubMed ID: 34026635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
